X0306 4 2021-07-29 0 0001841387 Candel Therapeutics, Inc. CADL 0001873465 Martell Christopher C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494 1 0 0 0 Common Stock 2021-07-29 4 C 0 283514 A 283514 I By GTAM1 2012 ADV LLC Common Stock 2021-07-29 4 P 0 125000 8.00 A 125000 I By GTAM1 2012 LLC Series B Preferred Stock 2021-07-29 4 C 0 696851 0.00 D Common Stock 283514 0 I By GTAM1 2012 ADV LLC These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any. Exhibit 24 - Power of Attorney /s/ John Canepa, Attorney-in-Fact 2021-08-02